Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

Complementary and Alternative Therapy Use in Children with Cerebral Palsy.

Authors:
Maryam Oskoui Pamela Ng Michele Zaman David Buckley Adam Kirton Esias van Rensburg Ellen Wood Michael Shevell Annette Majnemer

Can J Neurol Sci 2020 Aug 28:1-7. Epub 2020 Aug 28.

Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.

Objective: To describe complementary and alternative medicine (CAM) use amongst children with cerebral palsy (CP) in Canada and to identify factors associated with CAM use.

Methods: We conducted a cross-sectional study, utilising data from the Canadian CP Registry. We explored the association between CAM use and regional, socioeconomic and CP phenotypic variables, and parental perception of the family-centredness of clinical care using the Measures of Process of Care-56 (MPOC-56). Chi-square analyses were performed, and odds ratios (OR) and 95% confidence intervals (CI) were obtained. Mann-Whitney U tests were used to compare MPOC-56 scores between CAM users and non-CAM users.

Results: The study sample consisted of 313 families of which 27% reported CAM use in the past year. Children with CP using CAM were more likely to reside in Western Canada (OR 3.3, 95% CI 1.6-6.7), live in a two-parent household (OR 3.5, 95% CI 1.5-8.4), have an ataxic/hypotonic or dyskinetic CP subtype (OR 3.0, 95% CI 1.5-6.1) and have a greater motor impairment (OR 2.8, 95% CI 1.7-4.9). MPOC-56 subscale scores were not significantly associated with CAM use.

Conclusion: Physicians need to be aware of existing CAM therapies, the level of evidence supporting their efficacy (beneficence), their associated risks of adverse events (non-maleficence) and enable fair access to care that may be of benefit to each child.

Download full-text PDF

 Source
http://dx.doi.org/10.1017/cjn.2020.188DOI Listing
August 2020

Publication Analysis

Top Keywords

cerebral palsy
8
cam
8
children cerebral
8
associated cam
8
complementary alternative
8
95%
5
mpoc-56 chi-square
4
therapies level
4
care-56 mpoc-56
4
95% 17-49
4
chi-square analyses
4
children cam
4
analyses performed
4
odds ratios
4
cam year
4
performed odds
4
cam therapies
4
year children
4
process care-56
4
western canada
4

Keyword Occurance

Similar Publications

Vitamin D, Bone Mineral Density and Serum IGF-1 Level in Non-ambulatory Children with Cerebral Palsy.

Authors:
Namita Gwasikoti Kapil Bhalla Jaya Shankar Kaushik Veena Singh Ghalaut Zile Singh Kundu

Indian Pediatr 2021 Apr 17. Epub 2021 Apr 17.

Department of Orthopedics, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India.

Objectives: To compare serum 25-hydroxy vitamin D (25-OHD) status, bone mineral density and Insulin growth factor (IGF-1) level among children with cerebral palsy (CP) aged 1 to 8 years with age and gender matched controls.

Methods: A cross-sectional study enrolled thirty children in each group: CP with epilepsy, CP without epilepsy, and healthy controls and bone mineral density (BMD), serum 25-OHD levels, and serum insulin like growth factor (IGF)-1 levels were measured.

Results: Z scores of BMD [-1. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

The challenges of posterior drooling in children with cerebral palsy.

Authors:
Dinah S Reddihough Anne B Chang

Dev Med Child Neurol 2021 Apr 16. Epub 2021 Apr 16.

Australian Centre for Health Services Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.

View Article and Full-Text PDF
April 2021
Similar Publications

Barriers and facilitators of physical activity participation for people with disabilities: a parent's perspective.

Authors:
Cynthia Frisina

Dev Med Child Neurol 2021 Apr 16. Epub 2021 Apr 16.

Cerebral Palsy Foundation, New York, NY, USA.

View Article and Full-Text PDF
April 2021
Similar Publications

Septic Shock Caused by Rahnella aquatilis Bacteremia in an Immunocompetent Adult.

Authors:
Heidi A Roeder Benjamin Fuller Sarah Scoular

Am J Case Rep 2021 Apr 16;22:e930888. Epub 2021 Apr 16.

Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA.

BACKGROUND Rahnella aquatilis is a facultatively anaerobic, gram-negative rod bacterium commonly found in freshwater. There are few cases of bacteremia caused by Rahnella aquatilis in the literature and even fewer cases reported of it causing sepsis in immunocompetent individuals. In this case report, we present a rare case of an immunocompetent individual who developed sepsis secondary to bacteremia caused by Rahnella aquatilis. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Safety and efficacy of Botulinum toxin type A preparations in cerebral palsy - an evidence-based review.

Authors:
Marcin Bonikowski Jarosław Sławek

Neurol Neurochir Pol 2021 Apr 16. Epub 2021 Apr 16.

Dpt. of Neurology&Stroke, St. Adalbert Hospital, Al. Jana Pawła II 50, 80-462 Gdańsk, Poland.

The introduction of botulinum toxin more than 25 years ago for the management of paediatric lower and upper limb hypertonia has been a major advance. BoNT-A as a part of multimodal treatment supports motor development and improves function disturbed by spasticity or hypertonia. The aim of this paper was to compare the efficacy and safety of three major BoNT-A preparations present on the market: abo-, inco-, and onaobotulinumtoxinA in the treatment of children with cerebral palsy. Read More

View Article and Full-Text PDF
April 2021
Similar Publications